CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

Mintegra

Psycholeptics. Antipsychotics. Other antipsychotics. Aripiprazole.
Treatment of schizophrenia in adults. Treatment of moderate to severe manic episodes in bipolar I disorder, as well as for prevention of new manic episodes in adults who have previously experienced manic episodes and responded to the treatment with aripiprazole.
Characteristics of the productу:
    • Release formThe tablet is indivisible
    • ChildrenContraindicated
    • PregnantWith caution
    • NursingContraindicated
    • Release categoryPrescription medication
    • DiabeticsWith caution
    • With alcoholWith caution
    • DriversWith caution
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition
    • Pharmaceutical form
    • Pharmacotherapeutic group
    • Pharmacological properties
    • Clinical particulars
    • Therapeutic indications
    • Contraindications
    • Interaction with other medicinal products and other forms of interaction
    • Special warnings and precautions for use
    • Posology and method of administration
    • Overdose
    • Undesirable effects
    • Shelf life
    • Special precautions for storage
    • Nature and contents of container
    • Category of release
    • Marketing authorisation holder
    • The marketing authorisation holder's location and address of the place of business
    • Manufacturer
    • The manufacturer's location and address of the place of business
    • Date of last revision